Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep 13:82:104569.
doi: 10.1016/j.amsu.2022.104569. eCollection 2022 Oct.

Homozygous factor V leiden mutation: Rare etiology of pulmonary embolism

Affiliations
Case Reports

Homozygous factor V leiden mutation: Rare etiology of pulmonary embolism

Zakaria El Marraki et al. Ann Med Surg (Lond). .

Abstract

Introduction and importance: Venous thromboembolic disease (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis (DVT), is a major public health problem with high morbidity and mortality. The main risk factors for VTE are surgery, active cancer, immobilization, trauma or fracture, pregnancy and estrogen therapy. Genetic risk factors are also present and are dominated by the factor V Leiden mutation, which is present in 20% of VTE and in 2-5% of the general population with an annual incidence of 0.1% (Margaglione and Grandone, 2011; Ridker et al., 1995) [4,5]. This mutation can be heterozygous or homozygous, which is rarer. In this context, we report the case of a 37-year-old patient with no medical or surgical history and no notable risk factors who was admitted to the emergency room for the management of acute dyspnea at rest in connection with a bilateral proximal pulmonary embolism originating from a homozygous factor V Leiden mutation.Despite the efforts of the World Health organization, pulmonary embolism remains a major cause of morbidity and mortality in our days, and the etiological assessment is performed in a very few cases, which makes the management standardized and not specific. That is why it is important to make an etiological assessment in a systematic way especially in young subjects for an optimal management and to avoid recurrences.

Case presentation: Here, we report a rare case of a 37-year-old patient, who was admitted for the management of resting dyspnea related to bilateral proximal pulmonary embolism, in whom the etiological work-up was in favor of a homozygous factor V Leiden mutation. This case shows diagnostic difficulties and management of this rare disease.

Keywords: Case report; Homozygous factor V Leiden mutation; Pulmonary embolism; Thoracic angioscan.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
EKG showing negative T waves in the anteroseptal and inferior territories.
Fig. 2
Fig. 2
Short axis parasternal section showing dilatation of the right ventricle associated with flattening of the interventricular septum.
Fig. 3
Fig. 3
Apical section showing a right atrial thrombus(A), associated with a paradoxical septum(B).
Fig. 4
Fig. 4
Thoracic angioscan showing bilateral proximal pulmonary embolism.

References

    1. LeVarge B., Wright C., Rodriguez-Lopez J. Surgical management of acute and chronic pulmonary embo- lism. Clin. Chest Med. 2018;39:659–667. doi: 10.1016/j.ccm.2018.04.017. - DOI - PubMed
    1. Yavuz S., Toktas F., Goncu T., et al. Surgical embolectomy for acute massive pulmonary embolism. Int. J. Clin. Exp. Med. 2014;7 5362-5375. - PMC - PubMed
    1. Keeling W.B., Leshnower B.G., Lasajanak Y., et al. Midterm benefits of surgical pulmonary embolectomy for acute pulmonary embolus on right ventricular function. J. Thorac. Cardiovasc. Surg. 2016;152:872–878. doi: 10.1016/j.jtcvs.2015.11.042. - DOI - PubMed
    1. Margaglione M., Grandone E. Population genetics of venous thromboembolism. A narrative review. Thromb. Haemostasis. 2011;105:221–231. doi: 10.1160/TH10-08-0510. - DOI - PubMed
    1. Ridker P.M., Hennekens C.H., Lindpaintner K., et al. Mutation in the genecoding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N. Engl. J. Med. 1995;332:912–917. doi: 10.1056/NEJM199504063321403. - DOI - PubMed

Publication types